Wolfe Research maintains Paramount Skydance stock Underperform rating By Investing.com

Wolfe Research warns Paramount Skydance faces heavy leverage after the planned Warner merger with pro forma debt of $79B (>6.5x EBITDA) and estimates an equity raise of $13B–$25B to reduce leverage (to 5.0x–4.0x), which could imply ~35% dilution and push Class B shares toward $5–$6. Paramount currently carries $15.1B debt vs a $10.1B market cap and LTM EBITDA of $2.68B; the combined entity forecasts $69B pro forma revenue for FY2026, $18B adjusted EBITDA and $6B synergies, with the deal expected to close by end-Q3 2026. Analysts reacted with mixed views: Wolfe reiterates Underperform PT $10, Guggenheim raised PT to $14 (Neutral), UBS cut PT to $10, and MoffettNathanson downgraded WBD to Neutral (PT $31); Paramount also paid a $2.8B breakup fee to Netflix. Investors should weigh significant dilution and credit-rating risk against scale and projected synergies when positioning.

Analysis

A large-scale studio consolidation with heavy pro forma leverage creates a multi-stage pressure path: immediate equity overhang and investor skepticism, followed by a credit-market interrogation when refinancing windows open. That sequence amplifies valuation risk well before any operational integration benefits can be realized, so markets will price financing risk separate from synergy math for the next 6–12 months.

Second-order competitive effects favor flexible, cash-generative streaming platforms and distributors. If the combined studio needs to monetize assets to de-lever, expect accelerated licensing/sales of IP and output windows — that reduces exclusive content scarcity and puts downward pressure on marginal content pricing across the industry over 12–24 months.

From a creditors-and-banks perspective, the deal converts what would have been an operational story into a capital-structure one: covenant negotiation, tranche sizing, and timing of any equity backstop will determine recoveries and spreads. Underwriters and large banks will capture fee flow, but are also exposed to repricing risk if macro liquidity tightens within the 3–9 month window when the combined balance sheet is actively managed.

Catalysts to watch: equity issuance announcements, pre-close regulatory/approval milestones, and major rights renewals (sports in particular) that change near-term EBITDA visibility. The consensus is focused on headline synergies; markets should instead be trading liquidity and dilution pathways — that imbalance creates actionable relative-value opportunities ahead of the equity/credit execution timeline.

Key Decisions for Investors

• Short WBD equity via puts: Buy 9–12 month WBD puts sized ~1% portfolio notional at ~15–25% OTM to speculate on post-close dilution and repricing risk. R/R: limited premium vs potential >30% downside if a sizeable equity raise is priced; risk: total premium loss if deal executes cleanly and issuance is well absorbed.
• Pair trade — long NFLX / short WBD equity: Equal notional pair (e.g., +3% long NFLX stock, -3% short WBD) over 6–12 months to capture streaming demand resilience and relative funding stress on the combined studio. R/R: asymmetric — streaming upside if content pricing softens; risk: competitive content wins could hurt Netflix unexpectedly.
• Buy UBS exposure (event/fees play): Add a 6–12 month bullish call spread on UBS or a 1–2% tactical overweight in the stock to capture underwriting and advisory fee flow. Use a spread to cap premium; R/R: modest upside from elevated M&A fees vs limited downside if markets reprice banking multiples.
• Hedge credit via protection or bond selective buys: Purchase short-dated (3–5 year) single-name CDS protection on the combined entity or selectively buy high-yield paper only if spreads widen to capture extra carry. R/R: protection pays off if leverage-driven distress emerges; cost is running premium or mark-to-market if credit markets calm.